InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,528.00
(
0.90%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
72.91
(
0.00%
)
Bitcoin
68,462.51
(
-1.22%
)
Post# of 253510
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 169979

Friday, 11/15/2013 2:06:11 AM

Friday, November 15, 2013 2:06:11 AM

Post# of 253510
GILD already tested regimens of sofosbuvir + ledipasvir + either ribavirin or GS-9669 taken for 12 weeks in GT1 treatment-experienced with advanced liver fibrosis or cirrhosis in the ELECTRON trial and got SVR12 of 100%:

http://www.ic-hep.com/hepperspectives/aasld2013/library/PPTs/ELECTRON_Trial.pdf

So, I don't think GILD borrows a page from ABBV/ENTA rather they did try and still trying different combos to get rid of riba and shorten treatment duration.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up